Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration
US5491171A · kind A · utility
16Cited by
3References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 27, 1994 |
| Grant date | Feb 13, 1996 |
| Priority date | — |
| Expiry date | Jul 27, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical preparation for rectal or vaginal administration, comprising a prostaglandin compound and an alkali metal salt of a fatty acid having 8 to 12 carbon atoms, and a method for administering a prostaglandin compound, comprising rectally or vaginally administering same in the presence of an alkali metal salt of a fatty acid. According to the present invention, absorption of prostaglandin from rectum or vagina can be enhanced. The prostaglandin can be stabilized in the preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.